Cure for unpronounceable pharmaceutical company names ‘still distant’
Pharmaceutical companies are likely to continue to have unpronounceable names for the foreseeable future, according to researchers. ‘A cure won’t happen soon,’ said a spokesman for Pfizer which is making a bid for AstraZenec – or whatever they are called. ‘It’s still a distant prospect.’
Meanwhile a spokesman for GlaxoSmithKline claimed to have made some progress in discovering a pronounceable – if ungrammatical – name for a pharmaceutical company.
But French pharmaceutical Sanofi-Aventis said that the prospect of a Pfizer-AstraZenec company would create a new strain of the problem. ‘Most people can’t even pronounce ‘pharmaceutical’, a Sanofi-Aventis spokesman said. ‘ Or even ‘company.’Click to send this story to a friend
Posted: May 6th, 2014 by roybland
Click for more stories about: News In Brief